Based on the results obtained in the mouse model, chemerin circulating levels were evaluated in a cohort of hematopoietic stem cell transplantation (HSCT) pediatric hemato-oncological patients at risk of acute GvHD. Here, RARRES2 is linked to graft versus host disease.